-
Mashup Score: 0Cerenovus and Biosense Webster among brands newly incorporated into Johnson & Johnson MedTech - Cardiac Rhythm News - 9 month(s) ago
Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now go by the name ‘Johnson & Johnson MedTech’. This move “underscores J&J’s leadership in medical technology with a focus on cardiovascular, orthopaedic, surgery and vision solutions”, according to a company press release, […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Merit Medical signs agreement to purchase lead management portfolio from Cook Medical - 9 month(s) ago
Merit Medical Systems has announced that it recently signed a definitive asset purchase agreement to purchase Cook Medical’s lead management portfolio for a total cash consideration of approximately US$210 million. Merit expects to fund the transaction through a combination of cash on hand and borrowings under its long-term credit facility, as stated in a company […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
.@MeritMedical has announced that it recently signed a definitive asset purchase agreement to purchase @CookMedical's lead management portfolio for a total cash consideration of approximately US$210 million https://t.co/KD1STxomo5
-
-
Mashup Score: 5PULSE-EU: single-shot spherical array PFA catheter achieves good clinical efficacy at one year - 9 month(s) ago
The treatment of atrial fibrillation (AF) via a novel, ‘single-shot’ spherical array approach to pulsed field ablation (PFA) has been found to achieve durable and safe creation of cardiac tissue lesions, translating into “good clinical efficacy”, at one-year follow-up. That is according to the latest data from the first-in-human PULSE-EU trial evaluating the Globe PFA […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
The treatment of #AFib via a novel, ‘single-shot’ spherical array approach to PFA has achieved durable and safe creation of #Cardiac tissue lesions, translating into “good clinical efficacy”, at one-year follow-up @VivekReddyMD @hrs_journal @KardiumInc https://t.co/0wpiWfpkgU
-
-
Mashup Score: 1Final results from Medtronic’s EV ICD pivotal trial demonstrate high ATP success and effective defibrillation - 9 month(s) ago
Medtronic recently shared long-term results from the global EV ICD pivotal trial, reinforcing the performance and safety of the company’s extravascular implantable cardioverter defibrillator (EV-ICD) system, during a late-breaking clinical science presentation at the European Society of Cardiology (ESC) congress (30 August–2 September, London, UK). A Medtronic press release notes that the Aurora EV-ICD system […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
.@Medtronic recently shared long-term results from the global EV ICD trial, reinforcing the performance/safety of its extravascular implantable cardioverter defibrillator system, at the 2024 @escardio congress @MDT_Cardiac @MDT_EPAblation @NoStaticAtAll https://t.co/rX6YBwtMIg
-
-
Mashup Score: 7
Quitting cigarettes can significantly lower a person’s risk of atrial fibrillation (AF) compared to those who continue to smoke, according to a study published recently in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology. The findings show that the benefits of quitting start right away, suggesting that it is possible to reverse […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
Quitting cigarettes can significantly lower a person’s risk of #AFib compared to those who continue to smoke, and the benefits of quitting start right away, as per a recent @JACCJournals: Clinical #Electrophysiology study @gregorymmarcus @ACCinTouch https://t.co/e6BcoOvRbw
-
-
Mashup Score: 1Boston Scientific appoints Angelo Auricchio as chief medical officer for EMEA Rhythm Management business - 10 month(s) ago
Boston Scientific has announced the appointment of Angelo Auricchio as chief medical officer (CMO) of the company’s Rhythm Management business in Europe, the Middle East and Africa (EMEA). A renowned expert in cardiology and electrophysiology, Auricchio brings over 30 years of experience to this role, a Boston press release states. In his new position, Auricchio […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
.@bostonsci has announced the appointment of @AAuricchioMD as chief medical officer of the company’s Rhythm Management business in Europe, the Middle East and Africa (EMEA) @BSCCardiology @BSC_EU_Heart https://t.co/AoeryPtcdt
-
-
Mashup Score: 4ESC 2024: Widely performed additional ablation procedure deemed ineffective in persistent AF patients - 10 month(s) ago
In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in other areas of the heart—as per results from the SUPPRESS-AF randomised controlled trial (RCT), which were presented at this year’s European Society of Cardiology (ESC) congress (30 August–2 September, London, UK). […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet-
In patients with persistent AF, standard treatment with PVI ablation resulted in similar outcomes to more extensive ablation in other areas of the heart—as per results from the SUPPRESS-AF trial, which were presented at #ESCcongress2024 @escardio https://t.co/kOYSjGRDdo
-
-
Mashup Score: 1ESC 2024: Randomised trial shows education for healthcare professionals can improve AF guideline implementation - 10 month(s) ago
Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe—but, a structured educational programme for healthcare professionals was able to improve implementation of heart rhythm control recommendations in patients. These are among key findings from late-breaking research presented at the 2024 European Society of Cardiology (ESC) congress (30 […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
Adherence to #AF guidelines has been found to be 'poor' in clinical practice across Europe—but, structured education for healthcare professionals was able to improve implementation, as per a study presented at the recent @escardio meeting #ESCcongress2024 https://t.co/P385V5jToY
-
-
Mashup Score: 1Abbott brings “world's first” dual-chamber leadless pacemaker to the UK - 10 month(s) ago
Abbott has announced that, as of 6 September, it will be rolling out its Aveir dual-chamber (DR) leadless pacemaker system across the UK. In a press release, the company claims that Aveir DR is the “world’s first” dual-chamber leadless pacing system for the treatment of abnormal or slow heart rhythms. Owing to the fact that […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
.@AbbottCardio has announced that it will be rolling out its Aveir dual-chamber (DR) leadless #Pacemaker system for the treatment of abnormal or slow heart rhythms across the UK @AbbottNews https://t.co/XB21AQHscP
-
-
Mashup Score: 10ESC 2024: Wearable monitor increases diagnoses of common heart rhythm disorder by 50% - 10 month(s) ago
Screening for atrial fibrillation (AF) using a wearable heart monitor for two weeks can identify older adults with this potentially dangerous abnormal heart rhythm, but does not prevent subsequent strokes, according to late-breaking research presented recently at the European Society of Cardiology (ESC) congress (30 August–2 September, London, UK). The authors of the study in […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet-
Screening for #AF using a wearable heart monitor for two weeks can identify older adults with this abnormal heart rhythm, but does not prevent subsequent strokes, according to late-breaking research presented at #ESCcongress2024 @escardio @iRhythmTech https://t.co/V9LJRzvqyW
-
Biosense Webster is one of several companies to have been further incorporated under the @JNJMedTech umbrella as part of a recent brand update, and will now go by 'Johnson & Johnson MedTech Electrophysiology' @jjmt_ep @JNJNews https://t.co/a2ryYygpQ5